• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

康涅狄格州乳腺癌和宫颈癌早期检测项目承包商中宫颈癌筛查服务的种族/族裔差异。

Racial/Ethnic Disparities in Cervical Cancer Screening Services Among Contractors of the Connecticut Breast and Cervical Cancer Early Detection Program.

作者信息

Pratte Morgan A, Griffin Amy, Ogazi Chioma, Yurasevecz Susan, Blanks Carol A, McCooey Lisa, Kaufman Joy S

机构信息

Department of Family Medicine, SUNY Upstate Medical University, Syracuse, New York.

Program and Service System Evaluation, The Consultation Center, New Haven, Connecticut.

出版信息

Health Equity. 2018 Apr 1;2(1):30-36. doi: 10.1089/heq.2017.0038. eCollection 2018.

DOI:10.1089/heq.2017.0038
PMID:29696243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5909280/
Abstract

Racial/ethnic minority women are at increased risk for cervical cancer. The objective of this study is to use performance management data from the Connecticut Breast and Cervical Cancer Early Detection Program (CBCCEDP) to determine whether race/ethnicity disparities exist in human papillomavirus (HPV) co-testing uptake across CBCCEDP contractors. Secondary analysis of Connecticut's Minimum Data Elements data for 2013-2015 among 10 contractors participating in the CBCCEDP. Participants included women aged 30-64 years and eligible to receive routine cervical cancer screening services through the CBCCEDP (=5,262). HPV co-testing uptake was compared across contractors and race/ethnicity groups within each contractor using chi-square and Fisher's exact tests as appropriate. Overall, 62.9% of women received HPV co-testing services. Significant differences in co-testing rates were detected between racial/ethnic groups when data were examined across all contractors (<0.001). Black women were least likely to receive co-testing (49.1%), while Hispanic women were most likely to receive co-testing (68.2%). When data were examined at the individual contractor level, significant differences between racial/ethnic groups were observed in 50% of the contractors. This study identified racial/ethnic disparities in uptake of HPV co-testing both overall and within individual contractors involved in the CBCCEDP. These findings will be used to guide program improvement with the goal of increasing quality and consistency of care for all women seeking screening services.

摘要

种族/族裔少数群体女性患宫颈癌的风险更高。本研究的目的是利用康涅狄格州乳腺癌和宫颈癌早期检测项目(CBCCEDP)的绩效管理数据,以确定参与CBCCEDP的各承包商在人乳头瘤病毒(HPV)联合检测接受率方面是否存在种族/族裔差异。对参与CBCCEDP的10个承包商在2013 - 2015年期间的康涅狄格州最低数据元素数据进行二次分析。参与者包括年龄在30 - 64岁且有资格通过CBCCEDP接受常规宫颈癌筛查服务的女性(=5262人)。根据情况使用卡方检验和费舍尔精确检验,比较各承包商之间以及每个承包商内部不同种族/族裔群体的HPV联合检测接受率。总体而言,62.9%的女性接受了HPV联合检测服务。在检查所有承包商的数据时,发现种族/族裔群体之间的联合检测率存在显著差异(<0.001)。黑人女性接受联合检测的可能性最小(49.1%),而西班牙裔女性接受联合检测的可能性最大(68.2%)。在个体承包商层面检查数据时,50%的承包商中观察到种族/族裔群体之间存在显著差异。本研究确定了在CBCCEDP涉及的整体以及个体承包商内部,HPV联合检测接受率方面存在种族/族裔差异。这些发现将用于指导项目改进,目标是提高所有寻求筛查服务女性的护理质量和一致性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/5909280/d73333f8e08e/fig-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/5909280/9d18f3cfa8e7/fig-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/5909280/d73333f8e08e/fig-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/5909280/9d18f3cfa8e7/fig-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/5909280/d73333f8e08e/fig-2.jpg

相似文献

1
Racial/Ethnic Disparities in Cervical Cancer Screening Services Among Contractors of the Connecticut Breast and Cervical Cancer Early Detection Program.康涅狄格州乳腺癌和宫颈癌早期检测项目承包商中宫颈癌筛查服务的种族/族裔差异。
Health Equity. 2018 Apr 1;2(1):30-36. doi: 10.1089/heq.2017.0038. eCollection 2018.
2
Racial disparities in routine health checkup and adherence to cancer screening guidelines among women in the United States of America.美国女性在常规健康检查和癌症筛查指南依从性方面的种族差异。
Cancer Causes Control. 2021 Nov;32(11):1247-1256. doi: 10.1007/s10552-021-01475-5. Epub 2021 Jul 3.
3
Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty.人乳头瘤病毒 16/18 型在高级别宫颈病变中的个体和地理差异:与种族、民族和贫困的关联。
Cancer. 2013 Aug 15;119(16):3052-8. doi: 10.1002/cncr.28038. Epub 2013 May 9.
4
5
Barriers to mammography screening among racial and ethnic minority women.少数民族和种族女性进行乳房 X 光筛查的障碍。
Soc Sci Med. 2019 Oct;239:112494. doi: 10.1016/j.socscimed.2019.112494. Epub 2019 Aug 20.
6
Trends and Racial/Ethnic Differences in Predictors of Cervical Cancer Screening among US Women Ages 30-64 Years.美国 30-64 岁女性宫颈癌筛查预测因素的趋势和种族/民族差异。
Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):82-90. doi: 10.1158/1055-9965.EPI-22-0970.
7
Racial/Ethnic Disparities in Cervical Cancer Screening and Outcomes.宫颈癌筛查与结局中的种族/族裔差异
Acta Cytol. 2016;60(6):518-526. doi: 10.1159/000452240. Epub 2016 Nov 9.
8
Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.人乳头瘤病毒疫苗接种对美国 14-26 岁女性中疫苗型人乳头瘤病毒流行率的种族/民族差异的影响
Vaccine. 2018 Nov 29;36(50):7682-7688. doi: 10.1016/j.vaccine.2018.10.075. Epub 2018 Oct 28.
9
Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care.癌症筛查中的种族和民族差异:外国出生作为医疗障碍的重要性。
J Gen Intern Med. 2003 Dec;18(12):1028-35. doi: 10.1111/j.1525-1497.2003.20807.x.
10
Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).国家乳腺癌和宫颈癌早期检测项目(NBCCEDP)中医疗服务提供者的宫颈癌筛查与管理实践。
Cancer. 2007 Sep 1;110(5):1024-32. doi: 10.1002/cncr.22875.

引用本文的文献

1
Structural Racism in Cervical Cancer Care and Survival Outcomes: A Systematic Review of Inequities and Barriers.宫颈癌护理与生存结果中的结构性种族主义:对不平等与障碍的系统评价
Curr Epidemiol Rep. 2025;12(1):7. doi: 10.1007/s40471-025-00360-y. Epub 2025 Apr 26.
2
Associations of Pap test utilisation with comorbidity and functional impairment among middle-aged non-Hispanic black women in the USA: a cross-sectional analysis of the 2018 BRFSS data.美国中年非裔美国女性巴氏涂片检测利用与合并症和功能障碍的关联:2018 年 BRFSS 数据的横断面分析。
BMJ Open. 2024 Jul 24;14(7):e076247. doi: 10.1136/bmjopen-2023-076247.
3

本文引用的文献

1
Change in Provider Beliefs Regarding Cervical Cancer Screening Intervals After an Educational Intervention.教育干预后医疗服务提供者对宫颈癌筛查间隔看法的改变
J Womens Health (Larchmt). 2016 May;25(5):422-7. doi: 10.1089/jwh.2015.5706. Epub 2016 Apr 20.
2
Improving the Utilization of Human Papillomavirus and Cervical Cytology Co-testing for Cervical Cancer Screening in an Obstetrics and Gynecology Resident Clinic.提高妇产科住院医师诊所中用于宫颈癌筛查的人乳头瘤病毒和宫颈细胞学联合检测的利用率。
Hawaii J Med Public Health. 2015 Aug;74(8):267-9.
3
Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP.
Risk Factors for Cervical Cancer in Ghana.
加纳宫颈癌的风险因素。
Cancer Rep (Hoboken). 2024 Jun;7(6):e2124. doi: 10.1002/cnr2.2124.
4
Need for Sexual, Reproductive, and Mental Health Promotion Among Diverse College Students in a COVID-19 Era.新冠疫情时期多元化大学生群体的性健康、生殖健康和心理健康促进需求
Clin Child Fam Psychol Rev. 2023 Dec;26(4):1077-1096. doi: 10.1007/s10567-023-00460-5. Epub 2023 Nov 7.
5
Changing Preferences for a Cervical Cancer Screening Strategy: Moving Away from Annual Testing.宫颈癌筛查策略偏好的转变:摒弃年度检测
Womens Health Rep (New Rochelle). 2022 Aug 4;3(1):709-717. doi: 10.1089/whr.2022.0007. eCollection 2022.
6
A Brief Overview of Oncogenes and Signal Transduction Pathways in Gynecological Cancer.妇科癌症中癌基因与信号转导通路概述
Cancer Diagn Progn. 2022 Mar 3;2(2):134-143. doi: 10.21873/cdp.10087. eCollection 2022 Mar-Apr.
7
Cervical Cancer Prevention in Racially Disparate Rural Populations.种族差异农村人口中的宫颈癌预防
Medicines (Basel). 2019 Sep 4;6(3):93. doi: 10.3390/medicines6030093.
8
Barriers to accrual and enrollment in brain tumor trials.脑肿瘤试验入组和纳入的障碍。
Neuro Oncol. 2019 Sep 6;21(9):1100-1117. doi: 10.1093/neuonc/noz104.
解释国家乳腺癌和宫颈癌早期检测项目(NBCCEDP)中各受助方乳腺癌和宫颈癌筛查比例的差异。
Cancer Causes Control. 2015 May;26(5):689-95. doi: 10.1007/s10552-015-0569-5. Epub 2015 Apr 4.
4
Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.患者对人乳头瘤病毒检测及常规宫颈癌筛查中5年间隔时间的担忧。
Obstet Gynecol. 2015 Feb;125(2):317-329. doi: 10.1097/AOG.0000000000000638.
5
Using data to effectively manage a national screening program.利用数据有效管理国家筛查项目。
Cancer. 2014 Aug 15;120 Suppl 16(0 16):2575-83. doi: 10.1002/cncr.28821.
6
When performance management works: a study of the National Breast and Cervical Cancer Early Detection Program.绩效管理发挥作用时:对国家乳腺癌和宫颈癌早期检测项目的一项研究。
Cancer. 2014 Aug 15;120 Suppl 16(Suppl 16):2566-74. doi: 10.1002/cncr.28817.
7
Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning.国家乳腺癌和宫颈癌早期检测计划的实施:开端
Cancer. 2014 Aug 15;120 Suppl 16(0 16):2540-8. doi: 10.1002/cncr.28820.
8
Do interventions designed to support shared decision-making reduce health inequalities? A systematic review and meta-analysis.旨在支持共同决策的干预措施能否减少健康不平等?一项系统评价与荟萃分析。
PLoS One. 2014 Apr 15;9(4):e94670. doi: 10.1371/journal.pone.0094670. eCollection 2014.
9
Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers.患者的知识和信念是在联邦合格健康中心延长宫颈癌筛查间隔的障碍。
Prev Med. 2013 Nov;57(5):641-5. doi: 10.1016/j.ypmed.2013.08.021. Epub 2013 Sep 5.
10
Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers.初级保健提供者在联邦合格健康中心进行 HPV 检测的宫颈癌筛查的实践和信念。
Prev Med. 2013 Nov;57(5):419-25. doi: 10.1016/j.ypmed.2013.04.012. Epub 2013 Apr 28.